Koite Health Oy

Koite Health Oy is a Finnish health technology company based in Espoo that develops light-activated antibacterial solutions for treating and preventing oral diseases. The company describes itself as a quickly growing health technology innovator and a pioneer in light-enhanced antibacterial treatments, with a mission to improve health and quality of life through light-activated medical solutions. Its technology platform, branded KOITE, is designed to be scalable and expandable to other local infections such as skin infections, with the long-term ambition of becoming a global technology leader in photoactivated antibacterial therapies. Koite Health's first and flagship product is Lumoral, which combines light-activated therapy with a specialized Lumorinse mouthrinse to enhance oral health and combat common conditions such as tooth decay and gum disease caused by oral bacteria. The company positions Lumoral as a clinically proven treatment that treats and prevents gum inflammation. A second product line, Oncolum, is aimed at reducing oral mucositis and promoting mucosal healing during cancer therapy. By reducing reliance on antimicrobial medications, Koite Health argues that its treatments support oral health while helping to combat the growing threat of antimicrobial resistance (AMR). The company is based in the Nordics and presents itself as an award-winning team of doctors and engineers. Its stated core values are Innovation, Camaraderie, Hard Work and Honesty. Koite Health's board has included Seppo Mäkinen as Chairman and Tommi Pätilä as Chief Medical Officer, Co-Founder and Board member. The company operates through product-specific web presences for Lumoral and Oncolum alongside its corporate site, and it markets its offerings in Finland and internationally. It is a private company and, as of the available evidence, is not listed on a public stock exchange.

Koite Health Oy is a Finnish health technology company based in Espoo, Finland. It was founded to commercialize light-activated antibacterial technology, and it describes itself as a quickly growing health technology company and innovator in light-activated antibacterial solutions for treating and preventing oral diseases. The company's stated mission is to improve health and quality of life with light-activated medical solutions, and its vision is to be an innovator and global technology leader in photoactivated antibacterial therapies. Koite Health's first product, Lumoral, combines light-activated therapy with a specialized Lumorinse mouthrinse to enhance oral health and combat common conditions like tooth decay and gum disease caused by oral bacteria. The company built its business around the KOITE technology platform, which it describes as scalable and expandable to other local infections such as skin infections. Building on this platform, Koite Health has pursued applications beyond oral care, including Oncolum, which is aimed at reducing oral mucositis and promoting mucosal healing during cancer therapy, and future innovations in wound healing. By 2021, the company presented itself as an award-winning team of doctors and engineers based in the Nordics, with a board that included Seppo Mäkinen as Chairman and Tommi Pätilä as Chief Medical Officer, Co-Founder and Board member. The company operates product-specific web presences for Lumoral and Oncolum alongside its corporate website. It markets its offerings in Finland and internationally and positions its treatments as a way to reduce reliance on antimicrobial medications and help combat antimicrobial resistance (AMR). As of the available evidence, Koite Health Oy is a private company and is not listed on a public stock exchange.

• Koite Health's first product, Lumoral, combines light-activated therapy with a specialized Lumorinse mouthrinse.

• By 2021, the company presented itself as an award-winning team of doctors and engineers based in the Nordics.

• Oncolum is developed to reduce oral mucositis and promote mucosal healing during cancer therapy.

Pioneer in light-enhanced antibacterial treatments; clinically proven, antibiotic-reducing oral care and mucosal therapies.

• Lumoral

  Light-activated oral care system that treats and prevents gum inflammation through clinically proven light-activated therapy.

• Lumorinse

  Specialized mouthrinse used with the Lumoral system to enhance oral health and combat tooth decay and gum disease.

• Oncolum

  Product aimed at reducing oral mucositis and promoting mucosal healing during cancer therapy.

1. 1Koite Health – Light-based treatment for ultra clean teeth and healthy gums.koitehealth.com
2. 2New About us 2021 – Koite Healthkoitehealth.com
3. 3Koite Health Oy (Finland) – Wikidatawikidata.org